Procter & Gamble Acquires Thorne for $3.8 Billion

Procter & Gamble (PG) is acquiring supplement brand Thorne for $3.8 billion, as announced by CEO Shailesh Jejurikar. The acquisition aims to enhance P&G's health and wellness division, which already includes several other supplement brands. Thorne, founded in 1984, went public in 2021 at a valuation of $525 million, and became private again in 2023 for $680 million. P&G aims to cater to younger consumers amidst shifting health trends, as Thorne reported annual revenue exceeding $500 million in 2025, making this deal significant for the company's growth strategy.